Stay updated on Psilocybin for MDD: Novel Clinical Trial

Sign up to get notified when there's something new on the Psilocybin for MDD: Novel Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Psilocybin for MDD: Novel Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the lapse-in-government-funding notice and Revision: v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-11T04:23:24.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    New: a government funding notice about potential delays and open status guidance appears on the page. New: the page revision tag updated to v3.4.1, replacing v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T05:00:37.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    New: Show glossary toggle; added QC-related metadata labels—including 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'—while removing 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.
    Difference
    0.2%
    Check dated 2026-01-28T02:23:13.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.3.4 is now displayed, replacing v3.3.3. There are no changes to the study details on the page.
    Difference
    0.0%
    Check dated 2026-01-14T01:49:29.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The Locations section was expanded to include participating sites across multiple states under a consolidated listing, and older per-state subsections were removed with the revision updated to 3.3.3.
    Difference
    1%
    Check dated 2025-12-23T17:13:51.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Editorial notes were added to explain PubMed-derived publications and a revision label was updated; these changes do not modify the study's design, endpoints, eligibility criteria, or other core content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T16:59:44.000Z thumbnail image

Stay in the know with updates to Psilocybin for MDD: Novel Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Psilocybin for MDD: Novel Clinical Trial page.